AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma
- PMID: 24253341
- DOI: 10.3892/ijo.2013.2183
AHNAK is highly expressed and plays a key role in cell migration and invasion in mesothelioma
Abstract
The worldwide incidence of the highly aggressive tumor mesothelioma is expected to increase. Mesothelioma is classified into three main histological subtypes: epithelioid, sarcomatoid and biphasic. Although the pathological diagnostic markers for epithelioid are established, to date no adequate marker for sarcomatoid mesothelioma has been found. Thus, a reliable diagnostic marker of sarcomatoid mesothelioma is necessary. In this study, to identify an unknown protein with 120 kDa expressed only in the mesothelioma cell line 211H, we conducted proteomic analysis and found five candidate proteins. One such protein, AHNAK, was highly expressed in all seven mesothelioma cell lines (211H, H28, H226, H2052, H2452, MESO1 and MESO4), but not in the mesothelial cell line MeT-5A by RT-PCR and immunofluorescence staining. Furthermore, we confirmed high AHNAK expression not only in xenografts but also in human mesothelioma specimens including sarcomatoid, epithelioid and biphasic mesothelioma using immunohistochemical staining. These findings suggest that AHNAK has the potential to be a new marker for detecting mesothelioma. Since AHNAK is involved in cell migration and invasion in other metastatic tumor cells, we conducted migration and invasion assays in mesothelioma cell lines. The number of migrating cells in six of seven mesothelioma cell lines and the number of invading cells in all seven cell lines were significantly increased compared with those in MeT-5A. Knockdown of AHNAK significantly reduced the cell migration and invasion ability in all seven mesothelioma cell lines. These results support further clinical evaluation of the association of AHNAK and metastasis in mesothelioma.
Similar articles
-
Functional Analysis of the Adrenomedullin Pathway in Malignant Pleural Mesothelioma.J Thorac Oncol. 2016 Jan;11(1):94-107. doi: 10.1016/j.jtho.2015.09.004. J Thorac Oncol. 2016. PMID: 26762744
-
ZIC1 is silenced and has tumor suppressor function in malignant pleural mesothelioma.J Thorac Oncol. 2013 Oct;8(10):1317-28. doi: 10.1097/JTO.0b013e3182a0840a. J Thorac Oncol. 2013. PMID: 24457242
-
Differential expression of extracellular matrix constituents and cell adhesion molecules between malignant pleural mesothelioma and mesothelial hyperplasia.J Thorac Oncol. 2013 Nov;8(11):1389-95. doi: 10.1097/JTO.0b013e3182a59f45. J Thorac Oncol. 2013. PMID: 24084442
-
HMGB1 as a Potential Biomarker and Therapeutic Target for Malignant Mesothelioma.Dis Markers. 2019 Feb 12;2019:4183157. doi: 10.1155/2019/4183157. eCollection 2019. Dis Markers. 2019. PMID: 30891101 Free PMC article. Review.
-
Immunohistochemistry of pulmonary and pleural neoplasia.Arch Pathol Lab Med. 2008 Jul;132(7):1062-72. doi: 10.5858/2008-132-1062-IOPAPN. Arch Pathol Lab Med. 2008. PMID: 18605762 Review.
Cited by
-
O-GlcNAc-induced nuclear translocation of hnRNP-K is associated with progression and metastasis of cholangiocarcinoma.Mol Oncol. 2019 Feb;13(2):338-357. doi: 10.1002/1878-0261.12406. Epub 2019 Jan 10. Mol Oncol. 2019. PMID: 30444036 Free PMC article.
-
Transcriptomic analysis reveals the immune response of human microglia to a soy protein and collagen hybrid bioscaffold.Heliyon. 2023 Feb 1;9(2):e13352. doi: 10.1016/j.heliyon.2023.e13352. eCollection 2023 Feb. Heliyon. 2023. PMID: 36825181 Free PMC article.
-
Polyploidy of MDA-MB-231 cells drives increased extravasation with enhanced cell-matrix adhesion.APL Bioeng. 2025 Jan 29;9(1):016105. doi: 10.1063/5.0233329. eCollection 2025 Mar. APL Bioeng. 2025. PMID: 39974511 Free PMC article.
-
Comparison of Peptidomes Extracted from Healthy Tissue and Tumor Tissue of the Parotid Glands and Saliva Samples.Int J Mol Sci. 2024 Aug 13;25(16):8799. doi: 10.3390/ijms25168799. Int J Mol Sci. 2024. PMID: 39201484 Free PMC article.
-
AHNAKs roles in physiology and malignant tumors.Front Oncol. 2023 Nov 14;13:1258951. doi: 10.3389/fonc.2023.1258951. eCollection 2023. Front Oncol. 2023. PMID: 38033502 Free PMC article. Review.
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous